Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma

Proteomics - Clinical Applications

Volumn 7, Issue 9-10, 2013, Pages 690-700

  Comunale, Mary Ann ^a   Wang, Mengjun ^a   Anbarasan, Nikhil ^b   Betesh, Lucy ^a   Karabudak, Aykan ^b   Moritz, Ethan ^b   Devarajan, Karthik ^c   Marrero, Jorge ^d   Block, Timothy M ^a   Mehta, Anand ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BARUCH S BLUMBERG INSTITUTE   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cirrhosis; Glycomics; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; GLYCAN; LECTIN; POLYSACCHARIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; CANCER SURVIVAL; CARBOHYDRATE ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROPHORE LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TUMOR DIFFERENTIATION; ANIMAL; BLOOD; CARCINOMA, HEPATOCELLULAR; EARLY CANCER DIAGNOSIS; HEPACIVIRUS; HEPATITIS B VIRUS; LIVER NEOPLASMS; PHYSIOLOGY; PROCEDURES; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; LECTINS; LIVER NEOPLASMS; POLYSACCHARIDES;

EID: 84885938288     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200125     Document Type: Article

References (56)

1. Di Bisceglie, A. M., Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. Med. Clin. North. Am. 1989, 73, 985-997.
2. Block, T. M., Mehta, A. S., Fimmel, C. J., Jordan, R., Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22, 5093-5107.
3. Marrero, J. A., Hepatocellular carcinoma. Curr. Opin. Gastroenterol. 2006, 22, 248-253.
4. Sallie, R., Di Bisceglie, A. M., Viral hepatitis and hepatocellular carcinoma. Gastroenterol. Clin. North. Am. 1994, 23, 567-579.
5. Lok, A., McMahon, B., Chronic hepatitis B. Hepatology 2001, 34, 1225-1241.
6. Sherman, M., Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin. Liver Dis. 2005, 25, 143-154.
7. Anand, B. S., Cirrhosis of liver. West. J. Med. 1999, 171, 110-115.
8. Alpert, M. E., Uriel, J., de Nechaud, B., Alpha fetogloblin in the diagnosis of human hepatoma. N. Engl. J. Med. 1968, 278, 984-986.
9. Ruoslahti, E., Salaspuro, M., Pihko, H., Andersson, L. et al., Serum alpha-fetoprotein: diagnostic significance in liver disease. Br. Med. J. 1974, 2, 527-529.
10. Di Bisceglie, A. M., Hoofnagle, J. H., Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer 1989, 64, 2117-2120.
11. Comunale, M. A., Lowman, M., Long, R.E., Krakover, J. et al., Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 2006, 6, 308-315.
12. Wang, M., Long, R. E., Comunale, M. A., Junaidi, O. et al., Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 1914-1921.
13. Comunale, M. A., Wang, M., Hafner, J., Krakover, J. et al., Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J. Proteome Res. 2009, 8, 595-602.
14. Comunale, M. A., Rodemich-Betesh, L., Hafner, J., Wang, M. et al., Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma. PLoS ONE 2010, 5, e12419.
15. Mehta, A. S., Long, R. E., Comunale, M. A., Wang, M. et al., Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J. Virol. 2008, 82, 1259-1270.
16. Balagopal, A., Philp, F. H., Astemborski, J., Block, T. M. et al., Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 2008, 135, 226-233.
17. Guile, G. R., Rudd, P. M., Wing, D. R., Prime, S. B. et al., A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 1996, 240, 210-226.
18. Morota, K., Nakagawa, M., Sekiya, R., Hemken, P. M. et al., A comparative evaluation of Golgi protein-73, fucosylated hemopexin, alpha-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Clin. Chem. Lab. Med. 2011, 49, 711-718.
19. Guile, G. R., Rudd, P. M., Wing, D. R., Prime, S. B. et al., A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 1996, 240, 210-226.
20. Rudd, P. M., Dwek, R. A., Rapid, sensitive sequencing of oligosaccharides from glycoproteins. Curr. Opin. Biotechnol. 1997, 8, 488-497.
21. Rudd, P. M., Guile, G. R., Kuster, B., Harvey, D. J. et al., Oligosaccharide sequencing technology. Nature 1997, 388, 205-207.
22. Rudd, P. M., Colominas, C., Royle, L., Murphy, N., et al., A high-performance liquid chromatography based strategy for rapid, sensitive sequencing of N-linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands. Proteomics 2001, 1, 285-289.
23. Saldova, R., Royle, L., Radcliffe, C. M., Abd Hamid, U. M. et al., Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007, 17, 1344-1356.
24. Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F. et al., Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 779-784.
25. Arnold, J. N., Saldova, R., Galligan, M. C., Murphy, T. B. et al., Novel glycan biomarkers for the detection of lung cancer. J. Proteome Res. 2011, 10, 1755-1764.
26. Watt, K., Uhanova, J., Gong, Y., Kaita, K. et al., Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J. Viral Hepat. 2004, 11, 251-256.
27. Klein, A., Carre, Y., Louvet, A., Michalski, J. C., Morelle, W., Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients. Proteomics Clin Appl. 2010, 4, 379-393.
28. Liu, X. E., Desmyter, L., Gao, C. F., Laroy, W. et al., N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 2007, 46, 1426-1435.
29. Marrero, J. A., Romano, P. R., Nikolaeva, O., Steel, L. et al., GP73, a resident golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J. Hepatol. 2005, 43, 1007-1012.
30. Tang, Z., Varghese, R. S., Bekesova, S., Loffredo, C. A. et al., Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J. Proteome Res. 2010, 9, 104-112.
31. Buamah, P. K., Cornell, C., Cassells-Smith, A. J., Harris, A. L., Fucosylation of alpha-fetoprotein in hepatocellular carcinomas. Lancet 1986, 1, 922-923.
32. Aoyagi, Y., Suzuki, Y., Isemura, M., Nomoto, M. et al., The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988, 61, 769-774.
33. Turner, G. A., N-glycosylation of serum proteins in disease and its investigation using lectins. Clin. Chim. Acta 1992, 208, 149-171.
34. Aoyagi, Y., Suzuki, Y., Igarashi, K., Saitoh, A. et al., Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. Br. J. Cancer 1993, 67, 486-492.
35. Saitoh, A., Aoyagi, Y., Asakura, H., Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. Arch. Biochem. Biophys. 1993, 303, 281-287.
36. Turner, G. A., Haptoglobin. A potential reporter molecule for glycosylation changes in disease. Adv. Exp. Med. Biol. 1995, 376, 231-238.
37. Naitoh, A., Aoyagi, Y., Asakura, H., Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1999, 14, 436-445.
38. Comunale, M. A., Lowman, M., Long, R. E., Krakover, J. et al., Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 2006, 5, 308-315.
39. Wang, M., Long, R. E., Comunale, M. A., Junaidi, O. et al., Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 1914-1921.
40. Koda, M., Hori, T., Maeda, N., Kato, S. et al., Lectin-reactive patterns of markedly elevated serum alpha-fetoprotein in patients with chronic active hepatitis. Am. J. Gastroenterol. 1991, 86, 861-865.
41. Hirai, H., Taketa, K., Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma. J. Chromatogr. 1992, 604, 91-94.
42. Yamashiki, N., Seki, T., Wakabayashi, M., Nakagawa, T. et al., Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma. Oncol. Rep. 1999, 6, 1229-1232.
43. Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H. et al., Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009, 137, 110-118.
44. Lauc, G., Essafi, A., Huffman, J. E., Hayward, C. et al., Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet. 2010, 6, e1001256.
45. Saldova, R., Fan, Y., Fitzpatrick, J. M., Watson, R. W., Rudd, P. M., Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology 2011, 21, 195-205.
46. Callewaert, N., Van Vlierberghe, H., Van Hecke, A., Laroy, W. et al., Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat. Med. 2004, 10, 429-434.
47. Blomme, B., Van Steenkiste, C., Callewaert, N., Van Vlierberghe, H., Alteration of protein glycosylation in liver diseases. J. Hepatol. 2009, 50, 592-603.
48. Vanderschaeghe, D., Laroy, W., Sablon, E., Halfon, P. et al., GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol. Cell. Proteomics 2009, 8, 986-994.
49. Mehta, A., Norton, P., Liang, H., Comunale, M. A. et al., Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue. Cancer Epidemiol. Biomarkers Prev. 2012, 21, 925-933.
50. Sandler, N. G., Koh, C., Roque, A., Eccleston, J. L. et al., Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011, 141, 1220-1230, 1230 e1221-e1223.
51. Arnold, J. N., Saldova, R., Hamid, U. M., Rudd, P. M., Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008, 8, 3284-3293.
52. Sarrats, A., Saldova, R., Pla, E., Fort, E. et al., Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics Clin. Appl. 2010, 4, 432-448.
53. Phillips, M. L., Nudelman, E., Gaeta, F. C., Perez, M. et al., ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 1990, 250, 1130-1132.
54. Okada, Y., Usumoto, R., Muguruma, M., Shimoe, T. et al., The hepatocellular expression of a carbohydrate antigen 'sialyl Lewis X' in chronic hepatitis. A novel histological marker for active hepatic necroinflammation. J. Hepatol. 1990, 10, 1-7.
55. De Graaf, T. W., Van der Stelt, M. E., Anbergen, M. G., van Dijk, W., Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp. Med. 1993, 177, 657-666.
56. Bones, J., Mittermayr, S., O'Donoghue, N., Guttman, A., Rudd, P. M., Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. Anal. Chem. 2010, 82, 10208-10215.